Filter By Category
Archives
Share on -
ANAGESTONE
Generic Name: ANAGESTONE
ABSTRACT -
Anagestone is a synthetic pregnane progestin parent compound; its clinically known ester, anagestone acetate, was historically used in combined oral contraceptive products. Anagestone acetate was withdrawn from use, and the parent compound itself is not a routine modern therapeutic agent. The chemical representation above corresponds to the clinically recognised acetate ester form associated with anagestone history.
DOSAGE -
Dosage should be determined only by a qualified healthcare professional.
No modern approved standard dosing regimen is established for anagestone.
Historical contraceptive use involved anagestone acetate combinations, but these products are withdrawn or unavailable in most markets.
Do not use as contraception or hormone therapy unless a legally approved product and specialist direction exist.
SIDE EFFECTS–
- Possible side effects include:
- Nausea
- Breast tenderness
- Headache
- Mood changes
- Weight or fluid retention
- Irregular uterine bleeding
- Acne or skin changes
- Changes in libido
- Thromboembolic risk associated with hormonal contraceptive combinations
- Potential endocrine effects
ALLRGIC REACTIONS–
- Hypersensitivity to anagestone, anagestone acetate, steroidal hormones, or excipients may occur.
- Symptoms may include rash, urticaria, facial swelling, wheezing, or severe skin reaction.
- Important: Patients should seek medical care for allergic symptoms.
DRUG INTERACTIONS–
- Enzyme-inducing medicines may reduce effectiveness of hormonal contraceptives.
- Other hormonal therapies can increase endocrine adverse effects.
- Anticoagulants, antiepileptics, rifamycins, certain antiretrovirals, and herbal products such as St. John’s wort require specialist review.
- Smoking and oestrogen-containing combinations increase vascular risk.
PREAUTIONS–
- Avoid use in pregnancy, unexplained vaginal bleeding, hormone-sensitive malignancy, active thromboembolic disease, or severe liver disease unless specialist assessment supports therapy.
- Assess cardiovascular risk factors before hormone exposure.
- Use modern approved contraceptive options instead of withdrawn agents.
- Safety in lactation and paediatric use is not established.
WARNINGS –
- Anagestone-related historical products are not recommended for routine modern use.
- Hormonal agents can increase risk of blood clots, stroke, and liver problems in susceptible patients.
- Seek urgent care for chest pain, shortness of breath, severe headache, vision loss, or leg swelling.
- Keep out of reach of children.
Share on -
. Developed by